Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Han, S.-J. Articles by Chung, J. Search for Related Content PubMed PubMed Citation Articles by Han, S.-J. Articles by Chung, J.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, November 2005, p. 1285-1291, Vol. 12, No. 11
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.11.1285-1291.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Xylitol Inhibits Inflammatory Cytokine Expression Induced by Lipopolysaccharide from Porphyromonas gingivalis

Su-Ji Han,¹ So-Yeon Jeong,¹ Yun-Ju Nam,¹ Kyu-Ho Yang,² Hoi-Soon Lim,³ and Jin Chung^1*

Department of Oral Microbiology, School of Dentistry, Pusan National University, Pusan,¹ Department of Pediatric Dentistry, School of Dentistry, Chonnam National University, Kwangju,² Department of Dentistry, Chonnam National University Hwasun Hospital, Hwasun, Chonnam, Korea³

Received 28 April 2005/ Returned for modification 23 May 2005/ Accepted 28 July 2005

Top Abstract Introduction Materials and Methods Results Discussion References

 
Porphyromonas gingivalis is one of the suspected periodontopathic bacteria. The lipopolysaccharide (LPS) of P. gingivalis is a key factor in the development of periodontitis. Inflammatory cytokines play important roles in the gingival tissue destruction that is a characteristic of periodontitis. Macrophages are prominent at chronic inflammatory sites and are considered to contribute to the pathogenesis of periodontitis. Xylitol stands out and is widely believed to possess anticaries properties. However, to date, little is known about the effect of xylitol on periodontitis. The aim of the present study was to determine tumor necrosis factor alpha (TNF-) and interleukin-1ß (IL-1ß) expression when RAW 264.7 cells were stimulated with P. gingivalis LPS (hereafter, LPS refers to P. gingivalis LPS unless stated otherwise) and the effect of xylitol on the LPS-induced TNF- and IL-1ß expression. The kinetics of TNF- and IL-1ß levels in culture supernatant after LPS treatment showed peak values at 1 h (TNF-) and 2 to 4 h (IL-1ß), respectively. NF-B, a transcription factor, was also activated by LPS treatment. These cytokine expressions and NF-B activation were suppressed by pretreatment with pyrrolidine dithiocarbamate (an inhibitor of NF-B). Pretreatment with xylitol inhibited LPS-induced TNF- and IL-1ß gene expression and protein synthesis. LPS-induced mobilization of NF-B was also inhibited by pretreatment with xylitol in a dose-dependent manner. Xylitol also showed inhibitory effect on the growth of P. gingivalis. Taken together, these findings suggest that xylitol may have good clinical effect not only for caries but also for periodontitis by its inhibitory effect on the LPS-induced inflammatory cytokine expression.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Periodontal disease comprises a group of infections that leads to inflammation of the gingival tissues and destruction of periodontal tissues and, in severe cases, is accompanied by the loss of alveolar bone with eventual exfoliation of the teeth (28). Periodontitis results from infection with subgingival plaque-forming bacteria, followed by host immune responses. Although subgingival dental plaque is a complex microbial community in which more than 300 different species have been identified, a consensus view on the major potential periodontopathogens has emerged, and Porphyromonas gingivalis is now regarded to be one of the most important of these bacteria (20). P. gingivalis, a gram-negative anaerobic bacterium found in periodontal pocket, has been implicated as an important pathogen that plays a role in the initiation and progression of periodontitis (14, 37) and expresses numerous potential virulence factors.

Even though periodontal destruction is partly caused by proteinases secreted from bacteria, it is now accepted that host response to such bacterial products is the major cause of the pathogenesis (4, 15). Products of P. gingivalis, such as lipopolysaccharide (LPS), membrane proteins, and bacterial proteinases, are known to be able to induce the response of local cells for secreting high level of several cytokines that lead to periodontal tissue destruction (4). LPS is a major component of the outer membrane of gram-negative bacteria (42). Proinflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF-) initiate and augment subsequent inflammatory cascades, leading to tissue destruction (44). P. gingivalis LPS (hereafter, LPS refers to P. gingivalis LPS unless stated otherwise) differs from the LPS of enterobacterial species in its structural and functional properties (19, 29). It has been reported that LPS stimulates the induction of IL-1, IL-1ß, IL-6, and IL-8 by human gingival fibroblasts (31).

Xylitol stands out and is widely believed to possess anticaries properties. This fact indicates xylitol's superiority over the other sugar alcohols for potential caries control (reviewed in references 40 and 43). Xylitol is a polyol sugar alcohol and is referred to as birch sugar because it can be produced from birch. Natural sources of xylitol include plums, strawberries, raspberries, and rowanberries (26). The inhibitory effect of xylitol on the growth of Streptococcus mutans, one of primary causative agents of dental caries has been reported (7, 35, 45). However, little is known about the effect of xylitol on the growth of P. gingivalis or on periodontal disease.

Macrophages are prominent at chronic inflammatory sites, including periodontal disease, and are considered to contribute to the pathogenesis of the disease. Therefore, in the present study we determined the expression of proinflammatory cytokines such as TNF- and IL-1ß when mouse macrophage cell line, RAW 264.7 cells were stimulated with LPS. The effects of xylitol on the LPS-induced TNF- and IL-1ß expression and on the growth of P. gingivalis were also examined.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Reagents. Mouse TNF- and IL-1ß enzyme-linked immunosorbent assay (ELISA) kits were purchased from R&D Systems (Minneapolis, MN). Pyrrolidine dithiocarbamate (PDTC) was purchased from Calbiochem (San Diego, CA).

Bacterial culture. P. gingivalis A7A1-28 was cultured in brain heart infusion broth, which contained 5 mg of hemin and 0.5 mg of vitamin K/ml at 37°C in an anaerobic chamber in an atmosphere containing 90% N₂, 5% H₂, and 5% CO₂.

LPS purification. P. gingivalis was grown under anaerobic conditions and harvested at the end of the logarithmic phase of growth. LPS extraction was achieved by the hot phenol-water method (47). Briefly, the bacterial cell pellet was suspended in pyrogen-free water, and then an equal volume of 90% phenol at 60°C was added dropwise for 20 min and stirred constantly. The aqueous phase was separated by centrifugation at 7,000 rpm for 15 min at 4°C and collected. This process was repeated, and the aqueous phase was pooled and dialyzed against deionized water for 3 days at 4°C. The dialyzed LPS preparation was then centrifuged at 40,000 rpm for 1.5 h at 4°C in a Beckman (Palo Alto, CA) ultracentrifuge. The precipitate was suspended with 30 ml of pyrogen-free water, dialyzed against distilled water for 3 days, lyophilized, and stored at 4°C. LPS samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and stained for protein with Coomassie blue to confirm the purity of the LPS moieties.

Cell culture. The mouse macrophage cell line RAW 264.7 was purchased from American Type Culture Collection (Rockville, MD). Cells were maintained in Dulbecco modified Eagle medium with 10% fetal bovine serum (Life Technologies, Inc., Paisley, Scotland), 100 U of penicillin/ml, and 100 µg of streptomycin/ml and were incubated at 37°C in a humidified atmosphere of 5% CO₂.

RT-PCR. Total RNA was prepared from RAW 264.7 cells by using a reagent (TRIzol; Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The concentration of the RNA obtained was determined by measuring the absorbance at 260 and 280 nm. Total RNA (1 µg) isolated from each sample was used as a template for the cDNA synthesis. The reverse transcription (RT) of total RNA to cDNA was performed by using AccuPower RT PreMix (Bioneer Co., Daejeon, Korea). cDNA was amplified by PCR with a Perkin-Elmer thermal cycler (denaturation for 30 s at 95°C, annealing for 30 s at 60°C, and elongation for 30 s at 72°C) with TNF- (23 cycles), IL-1ß (30 cycles), or ß-actin primers (25 cycles). The primers used in these analysis were as follows: TNF-, 5'-CCT GTAGCCCACGTCGTAGC-3' and 5'-TTGACCTCAGCGCTGAGTTG-3'; IL-1ß, 5'-GATACAAACTGATGAAGCTCGTCA-3' and 5'-GAGATAGTG TTTGTCCACATCCTGA-3'; and ß-actin, 5'-GGGTCAGAACTCCTATG-3' and 5'-GTAACAATGCCATGTTCAAT-3'. A total of 20 µl of the RT-PCR products were separated in 1.2% (wt/vol) agarose gels and stained with ethidium bromide.

Measurement of TNF- and IL-1ß. The amounts of TNF- and IL-1ß released to the culture media after LPS stimulation were analyzed by using an ELISA kit from R&D systems (Minneapolis, MN). Briefly, standard or sample solution was added to an ELISA well plate, which had been precoated with specific monoclonal capture antibody. After incubation for 2 h at room temperature, polyclonal anti-TNF- or anti-IL-1ß antibody conjugated with horseradish peroxidase was added to the solution and incubated for 2 h at room temperature. Substrate solution containing hydrogen peroxidase and chromogen was added and allowed to react for 30 min. The levels of cytokine expression were assessed by ELISA reader at 450 nm. Each densitometric value expressed as mean ± the standard deviation (SD) was obtained from three independent experiments.

Nuclear extract preparation and gel shift assay. The nuclear extracts were prepared from RAW 264.7 cells according to a modification of the method of Dignam et al. (12). Briefly, cells were washed with ice-cold phosphate-buffered saline and pelleted. The cell pellet was resuspended in hypotonic buffer (10 mM HEPES [pH 7.9 at 4°C], 0.5 mM KCl, 1.5 mM MgCl₂, 0.5 mM dithiothreitol [DTT], 0.2 mM phenylmethylsulfonyl fluoride [PMSF]) and incubated for 10 min on ice; the cells were then lysed by the addition of 10% IGEPAL CA-630 (Sigma Chemical Co., St. Louis, MO), followed by vigorous vortexing for 10 s. Nuclei were pelleted and resuspended in low-salt buffer (20 mM HEPES [pH 7.9 at 4°C], 25% glycerol, 1.5 mM MgCl₂, 20 mM KCl, 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.2 mM PMSF) and added high-salt buffer (20 mM HEPES [pH 7.9 at 4°C], 1.5 mM MgCl₂, 0.8 M KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF) in a dropwise fashion. After 30 min of incubation at 4°C, the lysates were centrifuged, and supernatants containing the nuclear proteins were transferred to new vials. To inhibit endogenous protease activity, 1 mM PMSF was added. As a probe for the gel shift assay, an oligonucleotide containing the immunoglobulin -chain binding site (B, 5'-CCGGTTAACAGAGGGGGC TTTCCGAG-3') was synthesized. The two complementary strands were annealed and labeled with [-³²P]dCTP. Labeled oligonucleotides (10,000 cpm), 10 µg of nuclear extracts, and binding buffer [10 mM Tris-HCl (pH 7.6), 500 mM KCl, 10 mM EDTA, 50% glycerol, 100 ng of poly(dI-dC), 1 mM DTT] were incubated for 30 min at room temperature in a final volume of 20 µl. The reaction mixture was analyzed by electrophoresis on a 4% polyacrylamide gel in 0.5x Tris-borate buffer. Specific binding was controlled by competition with a 50-fold excess of cold B or cyclic AMP response element oligonucleotide.

Top Abstract Introduction Materials and Methods Results Discussion References

 
P. gingivalis LPS-induced gene expression and protein synthesis of TNF- and IL-1ß. TNF- is a proinflammatory cytokine and has been implicated as having an important functional role in the bone and tissue destruction in periodontitis. To clarify whether P. gingivalis LPS can induce TNF- and IL-1ß gene expression in mouse macrophage cell line, RAW 264.7 cells, these cells were treated with 1 µg of LPS/ml, and total RNA was prepared at 30 min, 1 h, 2 h, 4 h, and 8 h after LPS treatment. The time kinetics of TNF- and IL-1ß mRNA expression was examined by RT-PCR. The TNF- mRNA could be detected 30 min after LPS treatment and reached its maximum at 1 h and subsequently declined thereafter (Fig. 1A). The time kinetics of IL-1ß mRNA expression after LPS treatment showed peak values at 2 to 4 h (Fig. 1B). RAW 264.7 cells were treated with LPS, culture supernatants were collected at the indicated time points, and the protein production of TNF- and IL-1ß was measured by ELISA. TNF- production was evident 1 h after LPS treatment and was increased gradually (Fig. 1C). IL-1ß levels reached a peak 4 h after LPS treatment (Fig. 1D). These data indicate that P. gingivalis LPS can induce mRNA expression and protein production of TNF- and IL-1ß in the mouse macrophage cell line RAW 264.7.

View larger version (30K): [in this window] [in a new window]

FIG. 1. (A and B) Time kinetics of LPS-induced TNF- (A) and IL-1ß (B) mRNA expression. RAW 264.7 cells were treated with LPS (1 µg/ml), and total RNA was prepared at the times indicated. RT-PCR was performed as described in Materials and Methods. (C and D) Time kinetics of LPS-induced TNF- (C) and IL-1ß (D) protein production. RAW 264.7 cells were treated with 1 µg of LPS/ml, and the culture supernatants were collected at the times indicated. The levels of cytokine production in culture supernatants were measured by ELISA. Values are expressed as mean ± the SD obtained from three independent experiments.

NF-B mobilization by LPS. NF-B, a transcription factor, has a role in regulation of gene expression of proinflammatory cytokines. To elucidate a possible involvement of NF-B in LPS-induced TNF- and IL-1ß gene expression, the effect of LPS on the activation of NF-B in RAW 264.7 cells was investigated. For this purpose, a gel shift assay was conducted. When the cells were treated with 1 µg of LPS/ml for various time intervals, LPS markedly enhanced the binding of nuclear protein to the consensus sequences of the binding site for NF-B. It was reached a maximal level of binding at 30 min but declined gradually thereafter (Fig. 2A). LPS-induced NF-B activation was suppressed in the presence of the NF-B inhibitor, PDTC, at a concentration of 50 or 100 µM (Fig. 2B). The protein production of TNF- and IL-1ß induced by LPS was also inhibited by pretreatment with PDTC in a dose-dependent manner (Fig. 2C and D). These data suggest that the production of TNF- and IL-1ß by LPS may be regulated by NF-B at the transcriptional level.

View larger version (63K): [in this window] [in a new window]

FIG. 2. (A) LPS-induced NF-B activation in RAW 264.7 cells. These cells were stimulated with 1 µg of P. gingivalis LPS/ml for various time intervals. Nuclear extracts from RAW 264.7 cells after LPS treatment were incubated with -32P-labeled B oligonucleotide and electrophoresed on a 4% polyacrylamide gel. Lane p contained probe incubated without extract. (B) Effects of PDTC on the LPS-induced NF-B activation. RAW 264.7 cells were pretreated with various concentrations of PDTC for 30 min prior to treatment with 1 µg of LPS/ml. Nuclear extracts were prepared 30 min after LPS treatment, and a gel shift assay was performed. Lane p contained probe incubated without extract. A 50-fold excess of cold B or cAMP response element oligonucleotide was added as competitor. (C and D) Inhibition of TNF- (C) and IL-1ß (D) expression by PDTC. The cells were pretreated with PDTC (10, 50, or 100 µM) for 30 min prior to treatment with 1 µg of LPS/ml. Culture supernatants were collected 4 h after LPS treatment, and the production of TNF- and IL-1ß was measured by ELISA. Values are expressed as mean ± the SD obtained from three independent experiments.

Effects of xylitol on LPS-induced gene expression and protein synthesis of TNF- and IL-1ß. To clarify the effect of xylitol on LPS-induced TNF- and IL-1ß mRNA expression, RAW 264.7 cells were pretreated with 1, 2, 4, or 8% of xylitol 30 min prior to treatment with 1 µg of LPS/ml for 1 and 4 h, respectively. mRNA expression was examined by RT-PCR. Pretreatment with xylitol inhibited LPS-induced TNF- and IL-1ß mRNA expression in a dose-dependent manner. High doses of xylitol (4 or 8%) significantly inhibited TNF- and IL-1ß mRNA expression (Fig. 3A and B). Xylitol also inhibited TNF- and IL-1ß protein production increased by LPS in a dose-dependent manner (Fig. 3C and D). To rule out the hypothesis of toxicity of xylitol, cytolytic effects of xylitol were determined by measuring the cell viability by trypan blue exclusion. The xylitol concentrations used in the present study had no cytolytic effect on RAW 264.7 cells (data not shown).

View larger version (29K): [in this window] [in a new window]

FIG. 3. (A and B) Effects of xylitol on LPS-induced TNF- (A) and IL-1ß (B) mRNA expression. RAW 264.7 cells were pretreated with various concentrations of xylitol 30 min prior to treatment with 1 µg of LPS/ml. Total RNA was prepared 1 and 4 h after LPS treatment, and RT-PCR was performed. (C and D) Effects of xylitol on LPS-induced TNF- (C) and IL-1ß (D) protein production. RAW 264.7 cells were pretreated with various concentrations of xylitol 30 min prior to treatment with 1 µg of LPS/ml. Culture supernatants were collected 4 h after LPS treatment, and the production of TNF- and IL-1ß was measured by ELISA. Values are expressed as means ± the SD obtained from three independent experiments.

Inhibition of LPS-induced NF-B activation by xylitol. To investigate the effect of xylitol on LPS-induced NF-B activation, RAW 264.7 cells were pretreated with 1, 2, 4, or 8% of xylitol 30 min prior to treatment with 1 µg of LPS/ml. NF-B activation was examined by gel shift assay. LPS enhanced NF-B activation, and coincubation of LPS with increasing concentrations of xylitol resulted in a gradual decrease of NF-B activation (Fig. 4). These data indicate that the inhibitory effect of xylitol on the production of inflammatory cytokine is mediated by inhibition of NF-B activation.

View larger version (93K): [in this window] [in a new window]

FIG. 4. Effect of xylitol on LPS-induced NF-B activation. RAW 264.7 cells were pretreated with various concentrations of xylitol 30 min prior to treatment with 1 µg of LPS/ml. Nuclear extracts were prepared 30 min after LPS treatment, incubated with -32P-labeled B oligonucleotide, and electrophoresed on a 4% polyacrylamide gel. Lane p contained probe incubated without extract.

Inhibitory effect of xylitol on the growth of P. gingivalis. Since it has been well known that xylitol inhibits the growth of mutans streptococci (45), the effect of xylitol on the growth of P. gingivalis was investigated. P. gingivalis was cultured for 24 h in anaerobic conditions with various concentrations of xylitol (0, 2.5, 5, 10, or 20%) and was measured at an optical density at 660 nm using a spectrophotometer. The growth of P. gingivalis was inhibited in a dose-dependent manner and entirely blocked in medium containing 20% xylitol. This result indicates that xylitol can have an inhibitory effect on the pathogenesis of P. gingivalis by inhibition of the growth of P. gingivalis, as well as inhibition of inflammatory cytokine production.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Periodontitis is a bone disease that impacts human health and economics. P. gingivalis has been predominantly isolated from subgingival plaques and is thought to be a major etiologic agent in adult periodontitis. Although the etiology of this disease is unknown, an increase in proinflammatory cytokine expression has been reported in pathology (5, 17, 22, 41). Xylitol have been used to prevent dental caries for the past two decades (24, 32). Xylitol inhibits the growth of oral microorganisms, especially S. mutans, one of the primary causative agents of dental caries (45). However, the effect of xylitol on an individual who has periodontal disease has not yet been investigated.

The present study demonstrates that (i) P. gingivalis LPS stimulates gene expression and the protein production of TNF- and IL-1ß, (ii) NF-B is activated by LPS, (iii) xylitol inhibits LPS-induced gene expression and protein synthesis of TNF- and IL-1ß, (iv) xylitol inhibits LPS-induced NF-B activation, and (v) xylitol inhibits the growth of LPS.

P. gingivalis elicits gingival tissue destruction and alveolar bone resorption. Bacterial components of P. gingivalis, such as LPS, have also been demonstrated to have the ability to activate osteoclast formation indirectly by stimulating osteoclasts or inflammatory cells as a consequence of inducing inflammatory cytokines (9, 30). Among inflammatory cytokines, IL-1 and TNF- are thought to be pivotal factors in bone remodeling both in vitro and in vivo, and IL-6 has been observed in inflamed periodontal tissues (1, 2, 8, 10, 16, 18). Diseased gingival tissue expressed high levels of IL-1, TNF-, and IL-1 receptor antagonist mRNA in the connective tissue compared to healthy gingival tissue (27, 34). Similarly, expression of mRNA for IL-6, IL-10, and IL-13 was observed from locally and chronically inflamed gingival of patients with adult periodontitis (48). The present study showed that LPS from P. gingivalis led to induce mRNA expression and protein production of TNF- and IL-1ß in mouse macrophage cell line, RAW 264.7 cells (Fig. 1). Because the nature and the role of the broad array of proinflammatory cytokines in the pathogenesis of periodontal disease are still poorly understood, further studies are needed to determine whether other resorption-stimulating factors are involved, as well as to establish the precise roles of members of the cytokine network in the periodontal pathology.

NF-B is a multiunit transcription factor that plays a central role in induction of genes for proinflammatory cytokines (6, 11, 13, 36, 49) and many other immunoregulatory genes (3, 33). Thus, we investigated the possible involvement of NF-B in LPS-induced TNF- and IL-1ß expression in RAW 264.7 cells. LPS was a potent inducer of NF-B, and this LPS-induced NF-B activation and proinflammatory cytokine expression were suppressed by PDTC, an NF-B inhibitor (Fig. 2). These data suggest that LPS induces TNF- and IL-1ß gene expression through the activation of NF-B.

Xylitol is an artificial sweetener that has been successfully used in chewing gums to prevent dental caries (25, 38). It has been used as an oral sugar substitute without significant adverse effect (23). However, there are no studies examining the effects on the cells consisted of gingival tissues from patients with chronic periodontitis. Our present study demonstrated that xylitol is able to inhibit LPS-induced TNF- and IL-1ß gene expression and protein synthesis (Fig. 3) and that it is also able to inhibit LPS-induced NF-B activation by pretreatment with xylitol (Fig. 4). Furthermore, xylitol directly inhibited the growth of P. gingivalis (Fig. 5). These data suggest that the antiperiodontitis effect of xylitol could be obtained from dual mechanisms. One is from the inhibitory effect of xylitol on the production of inflammatory cytokines, which is regulated at the transcriptional level by NF-B. The other is that the growth of P. gingivalis is inhibited when it is cultured with xylitol. The inhibitory effect of xylitol on the growth of mutans streptococci has been widely known (21, 39, 46). The mechanism of xylitol on impaired growth of mutans streptococci is suggested to be an intracellular accumulation of xylitol 5-phosphate, and this xylitol 5-phosphate inhibits the activity of bacterial glycolytic enzymes (43).

View larger version (12K): [in this window] [in a new window]

FIG. 5. Inhibitory effect of xylitol on the growth of P. gingivalis. P. gingivalis was cultured with various concentrations of xylitol for 24 h in anaerobic conditions. The growth of P. gingivalis was measured by determining the optical density at 660 nm with a spectrophotometer.

Taken together with these data, xylitol may be a promising candidate as both an anticaries and an antiperiodontitis agent. We have shown here for the first time that xylitol can inhibit the periodontopathic effects induced by P. gingivalis LPS. To confirm the property of xylitol as an antiperiodontitis agent, further studies of xylitol on other inflammatory cytokines and other related factors are required.

 
This study was supported by Pusan National University research grant 2004 (S.-J.H.).

 
* Corresponding author. Mailing address: Department of Oral Microbiology, School of Dentistry, Pusan National University, Pusan, Korea 602-739. Phone: (82-51) 240-7815. Fax: (82-51) 254-0575. E-mail: jchung{at}pusan.ac.kr.

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Agarwal, S., C. Baran, N. P. Piesco, J. C. Quintero, H. H. Langkamp, L. P. Johns, and C. S. Chandra. 1995. Synthesis of proinflammatory cytokines by human gingival fibroblasts in response to lipopolysaccharides and interleukin-1ß. J. Periodontal Res. 30:382-389.[CrossRef][Medline]
2
2. Agarwal, S., N. P., Piesco, L. P. Johns, and A. E. Riccelli. 1995. Differential expression of IL-1ß, TNF-, IL-6 and IL-8 in human monocytes in response to lipopolysaccharides from different microbes. J. Dent. Res. 74:1057-1065.[Abstract/Free Full Text]
3
3. Baeuerle, P. A. 1991. The inducible transcription activator NF-B: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072:63-80.[Medline]
4
4. Birkedal-Hansen, H. 1993. Role of cytokines and inflammatory mediators in tissue destruction. J. Periodontal Res. 28:500-510.[CrossRef][Medline]
5
5. Birkedal-Hansen, H. 1993. Role of matrix metalloproteinases in human periodontal diseases. J. Periodontol. 64:474-484.[Medline]
6
6. Blank, V., P. Kourilsky, and A. Israel. 1992. NF-B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci. 17:135-140.[CrossRef][Medline]
7
7. Bradshaw, D. J., and P. D. Marsh. 1994. Effect of sugar alcohols on the composition and metabolism of a mixed culture of oral bacteria in a chemostat. Caries Res. 28:251-256.[Medline]
8
8. Canalis, E. 1986. Interleukin-1 had independent effects on deoxyribonucleic acid and collagen 2synthesis in cultures of rat calvariae. Endocrinology 118:74-81.[Abstract/Free Full Text]
9
9. Chen, L. L., and J. Yan. 2001. Porphyromonas gingivalis lipopolysaccharide activated bone resorption of osteoclasts by inducing IL-1, TNF, and PGE. Acta Pharmacol. Sin. 22:614-618.[Medline]
10
10. Chiang, C-Y, G. Kyritsis, D. T. Graves, and S. Amar. 1999. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect. Immun. 67: 4231-4236.[Abstract/Free Full Text]
11
11. Collart, M. A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor- transcription in macrophages: involvement of four B-like motifs and of constitutive and inducible forms of NF-B. Mol. Cell. Biol. 10:1498-1506.[Abstract/Free Full Text]
12
12. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.[Abstract/Free Full Text]
13
13. Drouet, C., A. N. Shakhov, and C. V. Jongeneel. 1991. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor- promoter in primary macrophages. J. Immunol. 147:1694-1700.[Abstract]
14
14. Dzink, J. L., S. S. Socransky, and A. D. Haffajee. 1988. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal disease. J. Clin. Periodontol. 15:316-323.[CrossRef][Medline]
15
15. Gemmell, E., R. I. Marshall, and G. J. Seymour. 1997. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol. 2000 14:112-143.[CrossRef]
16
16. Gowen, M., D. D. Wood, and R. G. Russel. 1985. Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity. J. Clin. Investig. 75:1223-1229.
17
17. Ingman, T., T. Sorsa, O. Lindy, H. Koski, and Y. T. Konttinen. 1994. Multiple forms of gelatinase/type IV collagenase in saliva and gingival crevicular fluid of periodontitis patients. J. Clin. Periodontol. 21:26-31.[CrossRef][Medline]
18
18. Ishihara, Y., T. Nishihara, E. Maki, T. Noguchi, and T. Koga. 1991. Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. J. Periodontal Res. 26:155-160.[CrossRef][Medline]
19
19. Kumada, H., Y. Haishima, T. Umemoto, and K. Tanamoto. 1995. Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis. J. Bacteriol. 177:2098-2106.[Abstract/Free Full Text]
20
20. Lamont, R. J., and H. F. Jenkinson. 1998. Life below the gum line. Pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62:1244-1263.[Abstract/Free Full Text]
21
21. Loesche, W. J. 1984. The effect of sugar alcohols on plaque and saliva level of Streptococcus mutans. Swed. Dent. J. 8:125-135.[Medline]
22
22. Makela, M., T. Salo, V. J. Uitto, and H. Larjava. 1994. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J. Dent. Res. 73:1397-1406.[Abstract/Free Full Text]
23
23. Makinen, K. K. 1976. Long-term tolerance of healthy human subjects to high amounts of xylitol and fructose: general and biochemical findings. Int. Z Vitam. Ernahrungsforsch. Beih. 15:92-104.
24
24. Makinen, K. K. 2000. The rocky road of xylitol to its clinical application. J. Dent. Res. 79:1352-1355.[Free Full Text]
25
25. Makinen, K. K., C. A. Bennett, P. P. Hujoel, P. J. Isokangas, K. P. Isotupa, H. R. Pape, Jr., and P. L. Makinen. 1995. Xylitol chewing gums and caries rates: a 40-month cohort study. J. Dent. Res. 74:1904-1913.[Abstract/Free Full Text]
26
26. Makinen, K. K., and E. Soderling. 1980. A quantitative study of mannitol, sorbitol, xylitol, and xylose in wild berries and commercial fruits. J. Food Sci. 45:367-371.[CrossRef]
27
27. Masada, M. P., R. Persson, J. S. Kenney, S. W. Lee, R. C. Page, and R. C. Allison. 1990. Measurement of interleukin-1 and -1ß in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J. Periodontal Res. 25:156-163.[CrossRef][Medline]
28
28. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2:253-258.[CrossRef][Medline]
29
29. Nair, B. C., W. R. Mayberry, R. Dziak, P. B. Chen, M. Levine, and E. Hausmann. 1983. Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis. J. Periodontal Res. 18:40-49.[CrossRef][Medline]
30
30. Nishida, E., Y. Hara, T. Kaneko, Y. Ikeda, T. Ukai, and I. Kato. 2001. Bone resorption and local interleukin-1 and interleukin-1ß synthesis induced by Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis lipopolysaccharide. J. Periodontal Res. 36:1-8.[CrossRef][Medline]
31
31. Ohmori, Y., S. Hanazawa, S. Amano, T. Miyoshi, K. Hirose, and S. Kitano. 1987. Spontaneous production of thymocyte-activating factor by human gingival fibroblasts and its autoregulatory effects on their proliferation. Infect. Immun. 55:947-954.[Abstract/Free Full Text]
32
32. Peldyak, J., and K. K. Makinen. 2002. Xylitol for caries prevention. J. Dent. Hyg. 76:276-285.[Medline]
33
33. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878-4884.[Abstract/Free Full Text]
34
34. Roberts, F. A., R. D. Hockett, R. P. Bucy, and S. M. Michalek. 1997. Quantitative assessment of inflammatory cytokine gene expression in chronic adult periodontitis. Oral Microbiol. Immunol. 12:336-344.[Medline]
35
35. Rogers, A. H., K. A. Pilowsky, P. S. Zilm, and N. J. Gully. 1991. Effects of pulsing with xylitol on mixed continuous cultures of oral streptococci. Aust. Dent. J. 36:231-235.[Medline]
36
36. Shakhov, A. N., M. A. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel. 1990. B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor- gene in primary macrophages. J. Exp. Med. 171:35-47.[Abstract/Free Full Text]
37
37. Slots, J., L. Bragd, M. Wikstrom, and G. Dahlen. 1986. The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis, and Bacteroides intermedius in destructive periodontal disease in adults. J. Clin. Periodontol. 13:570-577.[CrossRef][Medline]
38
38. Soderling, E., K. K. Makinen, C. Y. Chen, H. R. Pape, Jr., W. Loesche, and P. L. Makinen. 1989. Effect of sorbitol, xylitol, and xylitol/sorbitol chewing gums on dental plaque. Caries Res. 23:378-384.[Medline]
39
39. Söderling, E., L. Trahan, T. Tammiala-Salonen, and L. Häkkinen. 1997. Effects of xylitol, xylitol-sorbitol, and placebo chewing gums on the plaque of habitual xylitol consumers. Eur. J. Oral Sci. 105:170-177.[Medline]
40
40. Tanzer, J. M. 1995. Xylitol chewing gum and dental caries. Int. Dent. J. 45:65-76.[Medline]
41
41. Teng, Y. T., J. Sodek, and C. A. McCulloch. 1992. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J. Periodontal Res. 27:544-552.[CrossRef][Medline]
42
42. Tobias, P. S., J. Gegner, R. Tapping, R. S. Or, J. Methison, J. D. Lee, V. Kravchenko, J. Han, and R. J. Ulevitch. 1997. Lipopolysaccharide dependent cellular activation. J. Periodontal Res. 32:99-103.[CrossRef][Medline]
43
43. Trahan, L. 1995. Xylitol: a review of its action on mutans streptococci and dental plaque: its clinical significance. Int. Dent. J. 45:77-92.[Medline]
44
44. Unemori, E. N., N. Ehsani, M. Wang, S. Lee, J. McGuire, and E. P. Amento. 1994. Interleukin-1 and transforming growth factor-alpha: synergistic stimulation of metalloproteinases, PGE2, and proliferation in human fibroblasts. Exp. Cell Res. 210:166-171.[CrossRef][Medline]
45
45. Vadeboncoeur, C., L. Trahan, C. Mouton, and D. Mayrand. 1983. Effect of xylitol on the growth and glycolysis of acidogenic oral bacteria. J. Dent. Res. 62:882-884.[Abstract/Free Full Text]
46
46. Wennerholm, K., J. Arends, D. Birkhed, J. Ruben, C. G. Emilson, and A. G. Dijkman. 1994. Effect of xylitol and sorbitol in chewing-gums on mutans streptococci, plaque pH and mineral loss of enamel. Caries Res. 28:48-54.[Medline]
47
47. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol water and further applications of the procedure. Methods Carbohydr. Chem. 5:83-91.
48
48. Yamamoto, M., K. Fujihashi, T. Hiroi, J. R. McGhee, T. E. Van Dyke, and H. Kiyono. 1997. Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation. J. Periodontal Res. 32:115-119.[CrossRef][Medline]
49
49. Ziegler-Heitbrock, H. W., T. Sternsdorf, J. Liese, B. Belohradsky, C. Weber, A. Wedel, R. Schreck, P. Bauerle, and M. Strobel. 1993. Pyrrolidine dithiocarbamate inhibits NF-B mobilization and TNF production in human monocytes. J. Immunol. 151:6986-6993.[Abstract]

---

Clinical and Diagnostic Laboratory Immunology, November 2005, p. 1285-1291, Vol. 12, No. 11
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.11.1285-1291.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Han, S.-J. Articles by Chung, J. Search for Related Content PubMed PubMed Citation Articles by Han, S.-J. Articles by Chung, J.